HIV
News
FDA approves cabotegravir LA; New HIV PrEP option fills an important gap
“Being able to offer an injectable option is ... a game changer,” said Dr. Lina Rosengren-Hovee of UNC Health.
Latest News
HIV: FDA stops all islatravir oral and implant trials
The hold followed observations that total lymphocyte and T-cell counts had dropped in some participants receiving islatravir in clinical studies...
Conference Coverage
New hepatitis B vaccination recommendations praised amid low awareness
Only 25%-30% of adults in the U.S. are reported to be currently vaccinated for hepatitis B, even though safe and highly effective vaccines are...
Conference Coverage
HIV testing dips during pandemic raise transmission concerns
The number of CDC-funded HIV tests declined by more than 1 million in 2020 amid the COVID-19 restrictions.
Conference Coverage
Inadequate routine diabetes screening common in HIV
People with HIV are known to be at an increased risk of diabetes and the long-term complications of the disease.
News
New HIV PrEP guidelines call for clinicians to talk to patients about HIV prevention meds
Feature
Dr. Fauci: HIV advances ‘breathtaking,’ but steadfast focus on disparities needed
From the Journals
HIV: Syringe services fill the gap when clinicians refuse to prescribe PrEP to people who inject drugs
From the Journals
Geospatial maps show areas of Africa that need HIV services
Conference Coverage
HIV services are bouncing back from COVID-19 disruptions, data suggest, but recovery is ‘precarious’
From the Journals
Second woman spontaneously clears HIV: ‘We think more are out there’